OI5 (type III/IV OI) showed both high levels of inhibitory regulator DKK1 and osteoclast precursor RANKL and high expression levels of osteoblast and progenitor (SP7, BGLAP) markers well above both non‐OI controls and OI patients. Here, SP7 is linked to osteogenesis imperfecta.